Abstract
长期的Ticvas植入可能有助于CTEPH的发展,并对PEA后的围手术期生存产生负面影响。临床医生应意识到TICVA的这种潜在的晚期并发症。https://bit.ly/2omonhz
Footnotes
利益冲突:M。Jevnikar没有什么可披露的。
利益冲突:D。Montani报告了Actelion的赠款和个人费用,GSK和MSD的个人费用,来自拜耳的赠款,在提交的工作之外。
Conflict of interest: L. Savale reports grants and personal fees from Actelion, personal fees from GSK and MSD, grants from Bayer, outside the submitted work.
利益冲突:A。Seferian无话可说。
Conflict of interest: E-M. Jutant has nothing to disclose.
利益冲突:A。Boucly没有什么可披露的。
利益冲突:M。Perda无需披露。
利益冲突:J。Weatherald报告了Janssen Inc.和Actelion的赠款,个人费用和非财务支持,拜耳的个人费用和非财务支持,来自诺华的个人费用,来自提交的工作之外。
Conflict of interest: S. Bulifon has nothing to disclose.
Conflict of interest: F. Parent has nothing to disclose.
利益冲突:P。Brenot没有什么可披露的。
利益冲突:E。Fadel无需透露。
Conflict of interest: O. Sitbon reports grants and personal fees from Actelion, personal fees from GSK and MSD, grants from Bayer, outside the submitted work.
Conflict of interest: G. Simonneau reports grants and personal fees from Actelion, personal fees from GSK and MSD, grants from Bayer, outside the submitted work.
Conflict of interest: M. Humbert reports grants and personal fees from Actelion, personal fees from GSK and Merck, outside the submitted work.
利益冲突:X.Jaïs报告了Actelion的赠款和个人费用,GSK和MSD的个人费用,来自拜耳的赠款,在提交的工作之外。
- ReceivedJune 7, 2020.
- 公认July 9, 2020.
- 版权所有©ERS 2021